These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 28358229)

  • 1. Intractable Acute Pain Related to Fluoroquinolone-Induced Peripheral Neuropathy.
    Dukewich M; Danesh A; Onyima C; Gupta A
    J Pain Palliat Care Pharmacother; 2017 Jun; 31(2):144-147. PubMed ID: 28358229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoroquinolone-Associated Tendinopathy: Does Levofloxacin Pose the Greatest Risk?
    Bidell MR; Lodise TP
    Pharmacotherapy; 2016 Jun; 36(6):679-93. PubMed ID: 27138564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoroquinolones and peripheral neuropathy.
    Med Lett Drugs Ther; 2013 Nov; 55(1429):89. PubMed ID: 24220576
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluoroquinolone-Related Neuropsychiatric Events in Hospitalized Veterans.
    Sellick J; Mergenhagen K; Morris L; Feuz L; Horey A; Risbood V; Wojciechowski A; Ruh C; Bednarczyk E; Conway E; Ott M
    Psychosomatics; 2018; 59(3):259-266. PubMed ID: 29275962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of FDA black box warning on fluoroquinolone and alternative antibiotic use in southeastern US hospitals.
    Yarrington ME; Anderson DJ; Dodds Ashley E; Jones T; Davis A; Johnson M; Lokhnygina Y; Sexton DJ; Moehring RW
    Infect Control Hosp Epidemiol; 2019 Nov; 40(11):1297-1300. PubMed ID: 31474240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral neuropathy and Guillain-Barré syndrome risks associated with exposure to systemic fluoroquinolones: a pharmacovigilance analysis.
    Ali AK
    Ann Epidemiol; 2014 Apr; 24(4):279-85. PubMed ID: 24472364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preventable, life-altering case of fluoroquinolone-associated tendonitis.
    Wildermuth A; Holmes M
    JAAPA; 2022 Nov; 35(11):33-36. PubMed ID: 36282576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrolide and fluoroquinolone mediated cardiac arrhythmias: clinical considerations and comprehensive review.
    Cornett E; Novitch MB; Kaye AD; Pann CA; Bangalore HS; Allred G; Bral M; Jhita PK; Kaye AM
    Postgrad Med; 2017 Sep; 129(7):715-724. PubMed ID: 28770640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral neuropathy associated with fluoroquinolones.
    Cohen JS
    Ann Pharmacother; 2001 Dec; 35(12):1540-7. PubMed ID: 11793615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks associated with the use of fluoroquinolones.
    DeLaney MC
    Br J Hosp Med (Lond); 2018 Oct; 79(10):552-555. PubMed ID: 30290736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orofacial dyskinesia associated with the use of levofloxacin.
    Host BD; Sloan W
    Ann Pharmacother; 2014 Jan; 48(1):142-4. PubMed ID: 24259611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral fluoroquinolone use and risk of peripheral neuropathy: a pharmacoepidemiologic study.
    Etminan M; Brophy JM; Samii A
    Neurology; 2014 Sep; 83(14):1261-3. PubMed ID: 25150290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA adds "black box" warning label to fluoroquinolone antibiotics.
    Tanne JH
    BMJ; 2008 Jul; 337(7662):a816. PubMed ID: 18632714
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug-induced immune haemolytic anaemia caused by levofloxacin.
    Sukhal S; Gupta S
    Singapore Med J; 2014 Aug; 55(8):e136-8. PubMed ID: 25189315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between inpatient fluoroquinolone use and Clostridium difficile-associated diarrhea.
    Novell MJ; Morreale CA
    Ann Pharmacother; 2010 May; 44(5):826-31. PubMed ID: 20354161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leave the levofloxacin? A case report of levofloxacin-induced psychosis.
    Steuber H; Williams D; Rech MA
    Am J Emerg Med; 2018 Aug; 36(8):1528.e1-1528.e2. PubMed ID: 29779676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High rate of coadministration of di- or tri-valent cation-containing compounds with oral fluoroquinolones: risk factors and potential implications.
    Barton TD; Fishman NO; Weiner MG; LaRosa LA; Lautenbach E
    Infect Control Hosp Epidemiol; 2005 Jan; 26(1):93-9. PubMed ID: 15693415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reoccurrence of levofloxacin-induced tendinitis by phenoxymethylpenicillin therapy after 6 months: a rare complication of fluoroquinolone therapy?
    Schindler C; Pittrow D; Kirch W
    Chemotherapy; 2003 May; 49(1-2):90-1. PubMed ID: 12756981
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fluoroquinolone-induced Achilles tendon rupture].
    Maurin N
    Dtsch Med Wochenschr; 2008 Feb; 133(6):241-4. PubMed ID: 18236349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Permanent Peripheral Neuropathy: A Case Report on a Rare but Serious Debilitating Side-Effect of Fluoroquinolone Administration.
    Francis JK; Higgins E
    J Investig Med High Impact Case Rep; 2014; 2(3):2324709614545225. PubMed ID: 26425618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.